Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Tuberculosis Exacerbates HIV-1 Infection through IL-10/STAT3-Dependent Tunneling Nanotube Formation in Macrophages.

Souriant S, Balboa L, Dupont M, Pingris K, Kviatcovsky D, Cougoule C, Lastrucci C, Bah A, Gasser R, Poincloux R, Raynaud-Messina B, Al Saati T, Inwentarz S, Poggi S, Moraña EJ, González-Montaner P, Corti M, Lagane B, Vergne I, Allers C, Kaushal D, Kuroda MJ, Sasiain MDC, Neyrolles O, Maridonneau-Parini I, Lugo-Villarino G, Vérollet C.

Cell Rep. 2019 Mar 26;26(13):3586-3599.e7. doi: 10.1016/j.celrep.2019.02.091.

2.

CCR5 structural plasticity shapes HIV-1 phenotypic properties.

Colin P, Zhou Z, Staropoli I, Garcia-Perez J, Gasser R, Armani-Tourret M, Benureau Y, Gonzalez N, Jin J, Connell BJ, Raymond S, Delobel P, Izopet J, Lortat-Jacob H, Alcami J, Arenzana-Seisdedos F, Brelot A, Lagane B.

PLoS Pathog. 2018 Dec 6;14(12):e1007432. doi: 10.1371/journal.ppat.1007432. eCollection 2018 Dec.

3.

CCR5 adopts three homodimeric conformations that control cell surface delivery.

Jin J, Momboisse F, Boncompain G, Koensgen F, Zhou Z, Cordeiro N, Arenzana-Seisdedos F, Perez F, Lagane B, Kellenberger E, Brelot A.

Sci Signal. 2018 May 8;11(529). pii: eaal2869. doi: 10.1126/scisignal.aal2869.

PMID:
29739880
4.

Buffering deleterious polymorphisms in highly constrained parts of HIV-1 envelope by flexible regions.

Gasser R, Hamoudi M, Pellicciotta M, Zhou Z, Visdeloup C, Colin P, Braibant M, Lagane B, Negroni M.

Retrovirology. 2016 Jul 30;13(1):50. doi: 10.1186/s12977-016-0285-6.

5.

Guidelines for cloning, expression, purification and functional characterization of primary HIV-1 envelope glycoproteins.

Benureau Y, Colin P, Staropoli I, Gonzalez N, Garcia-Perez J, Alcami J, Arenzana-Seisdedos F, Lagane B.

J Virol Methods. 2016 Oct;236:184-195. doi: 10.1016/j.jviromet.2016.07.019. Epub 2016 Jul 20.

PMID:
27451265
6.

A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity.

Garcia-Perez J, Staropoli I, Azoulay S, Heinrich JT, Cascajero A, Colin P, Lortat-Jacob H, Arenzana-Seisdedos F, Alcami J, Kellenberger E, Lagane B.

Retrovirology. 2015 Jun 18;12:50. doi: 10.1186/s12977-015-0177-1.

7.

Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.

Jin J, Colin P, Staropoli I, Lima-Fernandes E, Ferret C, Demir A, Rogée S, Hartley O, Randriamampita C, Scott MG, Marullo S, Sauvonnet N, Arenzana-Seisdedos F, Lagane B, Brelot A.

J Biol Chem. 2014 Jul 4;289(27):19042-52. doi: 10.1074/jbc.M114.559831. Epub 2014 May 22.

8.

Modeling the allosteric modulation of CCR5 function by Maraviroc.

Lagane B, Garcia-Perez J, Kellenberger E.

Drug Discov Today Technol. 2013 Summer;10(2):e297-305. doi: 10.1016/j.ddtec.2012.07.011. Review.

PMID:
24050281
9.

HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.

Colin P, Bénureau Y, Staropoli I, Wang Y, Gonzalez N, Alcami J, Hartley O, Brelot A, Arenzana-Seisdedos F, Lagane B.

Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9475-80. doi: 10.1073/pnas.1222205110. Epub 2013 May 21.

10.

β-arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6.

Borroni EM, Cancellieri C, Vacchini A, Benureau Y, Lagane B, Bachelerie F, Arenzana-Seisdedos F, Mizuno K, Mantovani A, Bonecchi R, Locati M.

Sci Signal. 2013 Apr 30;6(273):ra30.1-11, S1-3. doi: 10.1126/scisignal.2003627. Erratum in: Sci Signal. 2013 Aug 13;6(288):er5.

PMID:
23633677
11.

CCR5 mutations distinguish N-terminal modifications of RANTES (CCL5) with agonist versus antagonist activity.

Choi WT, Nedellec R, Coetzer M, Colin P, Lagane B, Offord RE, Hartley O, Mosier DE.

J Virol. 2012 Sep;86(18):10218-20. doi: 10.1128/JVI.00353-12. Epub 2012 Jul 11.

12.

Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5).

Garcia-Perez J, Rueda P, Alcami J, Rognan D, Arenzana-Seisdedos F, Lagane B, Kellenberger E.

J Biol Chem. 2011 Sep 23;286(38):33409-21. doi: 10.1074/jbc.M111.279596. Epub 2011 Jul 20.

13.

New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection.

Garcia-Perez J, Rueda P, Staropoli I, Kellenberger E, Alcami J, Arenzana-Seisdedos F, Lagane B.

J Biol Chem. 2011 Feb 18;286(7):4978-90. doi: 10.1074/jbc.M110.168955. Epub 2010 Nov 30.

14.

CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.

Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B.

Blood. 2009 Jun 11;113(24):6085-93. doi: 10.1182/blood-2008-12-196618. Epub 2009 Apr 20.

PMID:
19380869
15.

Cholesterol content drives distinct pharmacological behaviours of micro-opioid receptor in different microdomains of the CHO plasma membrane.

Gaibelet G, Millot C, Lebrun C, Ravault S, Sauliere A, Andre A, Lagane B, Lopez A.

Mol Membr Biol. 2008 Aug;25(5):423-35. doi: 10.1080/09687680802203380.

PMID:
18651319
16.

The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins.

Rueda P, Balabanian K, Lagane B, Staropoli I, Chow K, Levoye A, Laguri C, Sadir R, Delaunay T, Izquierdo E, Pablos JL, Lendinez E, Caruz A, Franco D, Baleux F, Lortat-Jacob H, Arenzana-Seisdedos F.

PLoS One. 2008 Jul 2;3(7):e2543. doi: 10.1371/journal.pone.0002543.

17.

Small neutralizing molecules to inhibit actions of the chemokine CXCL12.

Hachet-Haas M, Balabanian K, Rohmer F, Pons F, Franchet C, Lecat S, Chow KY, Dagher R, Gizzi P, Didier B, Lagane B, Kellenberger E, Bonnet D, Baleux F, Haiech J, Parmentier M, Frossard N, Arenzana-Seisdedos F, Hibert M, Galzi JL.

J Biol Chem. 2008 Aug 22;283(34):23189-99. doi: 10.1074/jbc.M803947200. Epub 2008 Jun 13.

18.

CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.

Lagane B, Chow KY, Balabanian K, Levoye A, Harriague J, Planchenault T, Baleux F, Gunera-Saad N, Arenzana-Seisdedos F, Bachelerie F.

Blood. 2008 Jul 1;112(1):34-44. doi: 10.1182/blood-2007-07-102103. Epub 2008 Apr 24.

19.

Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.

Balabanian K, Levoye A, Klemm L, Lagane B, Hermine O, Harriague J, Baleux F, Arenzana-Seisdedos F, Bachelerie F.

J Clin Invest. 2008 Mar;118(3):1074-84. doi: 10.1172/JCI33187.

20.

CD4 interacts constitutively with multiple CCR5 at the plasma membrane of living cells. A fluorescence recovery after photobleaching at variable radii approach.

Baker AM, Saulière A, Gaibelet G, Lagane B, Mazères S, Fourage M, Bachelerie F, Salomé L, Lopez A, Dumas F.

J Biol Chem. 2007 Nov 30;282(48):35163-8. Epub 2007 Sep 13.

21.

Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G(alpha)(i) activation.

Berchiche YA, Chow KY, Lagane B, Leduc M, Percherancier Y, Fujii N, Tamamura H, Bachelerie F, Heveker N.

J Biol Chem. 2007 Feb 23;282(8):5111-5. Epub 2006 Dec 29. Erratum in: J Biol Chem. 2011 Aug 19;286(33):29440.

22.

CD4 and CCR5 constitutively interact at the plasma membrane of living cells: a confocal fluorescence resonance energy transfer-based approach.

Gaibelet G, Planchenault T, Mazères S, Dumas F, Arenzana-Seisdedos F, Lopez A, Lagane B, Bachelerie F.

J Biol Chem. 2006 Dec 8;281(49):37921-9. Epub 2006 Oct 11.

23.

The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes.

Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F.

J Biol Chem. 2005 Oct 21;280(42):35760-6. Epub 2005 Aug 17.

24.

Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis.

Lagane B, Ballet S, Planchenault T, Balabanian K, Le Poul E, Blanpain C, Percherancier Y, Staropoli I, Vassart G, Oppermann M, Parmentier M, Bachelerie F.

Mol Pharmacol. 2005 Jun;67(6):1966-76. Epub 2005 Mar 10.

PMID:
15761117
25.

CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes.

Balabanian K, Harriague J, Décrion C, Lagane B, Shorte S, Baleux F, Virelizier JL, Arenzana-Seisdedos F, Chakrabarti LA.

J Immunol. 2004 Dec 15;173(12):7150-60.

26.

WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.

Balabanian K, Lagane B, Pablos JL, Laurent L, Planchenault T, Verola O, Lebbe C, Kerob D, Dupuy A, Hermine O, Nicolas JF, Latger-Cannard V, Bensoussan D, Bordigoni P, Baleux F, Le Deist F, Virelizier JL, Arenzana-Seisdedos F, Bachelerie F.

Blood. 2005 Mar 15;105(6):2449-57. Epub 2004 Nov 9.

PMID:
15536153
27.

Dynamic confinement of NK2 receptors in the plasma membrane. Improved FRAP analysis and biological relevance.

Cézanne L, Lecat S, Lagane B, Millot C, Vollmer JY, Matthes H, Galzi JL, Lopez A.

J Biol Chem. 2004 Oct 22;279(43):45057-67. Epub 2004 Aug 3.

28.

HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains.

Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, Virelizier JL, Arenzana-Seisdedos F, Hoessli DC, Bachelerie F.

J Biol Chem. 2003 Jan 31;278(5):3153-61. Epub 2002 Nov 12.

29.

Lateral distribution of cholesterol in membranes probed by means of a pyrene-labelled cholesterol: effects of acyl chain unsaturation.

Lagane B, Mazères S, Le Grimellec C, Cézanne L, Lopez A.

Biophys Chem. 2002 Jan 23;95(1):7-22.

PMID:
11880170
30.

Probing the lateral organization of membranes: fluorescence repercussions of pyrene probe distribution.

Mazères S, Lagane B, Welby M, Trégou V, Lopez A.

Spectrochim Acta A Mol Biomol Spectrosc. 2001 Sep 14;57(11):2297-311.

PMID:
11603845
31.

Role of sterols in modulating the human mu-opioid receptor function in Saccharomyces cerevisiae.

Lagane B, Gaibelet G, Meilhoc E, Masson JM, Cézanne L, Lopez A.

J Biol Chem. 2000 Oct 27;275(43):33197-200.

Supplemental Content

Loading ...
Support Center